Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and diabetes mellitus: from pathophysiology to clinical management
Soo Lim, Jae Hyun Bae, Hyuk‐Sang Kwon, et al.
Nature Reviews Endocrinology (2020) Vol. 17, Iss. 1, pp. 11-30
Open Access | Times Cited: 925

Showing 1-25 of 925 citing articles:

Type 2 diabetes
Ehtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
The Lancet (2022) Vol. 400, Iss. 10365, pp. 1803-1820
Closed Access | Times Cited: 522
Diabetes Fact Sheet in Korea 2021
Jae Hyun Bae, Kyungdo Han, Seung‐Hyun Ko, et al.
Diabetes & Metabolism Journal (2022) Vol. 46, Iss. 3, pp. 417-426
Open Access | Times Cited: 264
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 239
Nitric oxide signalling in kidney regulation and cardiometabolic health
Mattias Carlström
Nature Reviews Nephrology (2021) Vol. 17, Iss. 9, pp. 575-590
Open Access | Times Cited: 182
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries
Shivaprakash M. Rudramurthy, Martin Hoenigl, Jacques F. Meis, et al.
Mycoses (2021) Vol. 64, Iss. 9, pp. 1028-1037
Open Access | Times Cited: 175
Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2
Moritz Reiterer, Mangala Rajan, Nicolás Gómez-Banoy, et al.
Cell Metabolism (2021) Vol. 33, Iss. 11, pp. 2174-2188.e5
Open Access | Times Cited: 161
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Michelle A. Erickson, Elizabeth M. Rhea, Rachel C. Knopp, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2681-2681
Open Access | Times Cited: 129
Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA)
Edina Cenko, Lina Badimón, Raffaele Bugiardini, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 14, pp. 2705-2729
Open Access | Times Cited: 127
Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions
Jia-Xu Li, Carolyn L. Cummins
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 9, pp. 540-557
Open Access | Times Cited: 124
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
Vivek P. Chavda, Jinal Ajabiya, Divya Teli, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4315-4315
Open Access | Times Cited: 119
COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Xiaohuan Xia, Yi Wang, Jialin Zheng
Translational Neurodegeneration (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 118
Virus Infections and Host Metabolism—Can We Manage the Interactions?
Deepak Sumbria, Engin Berber, Manikannan Mathayan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 113
Impact of COVID-19 on the Endocrine System: A Mini-review
Sophie Clarke, Ali Abbara, Waljit S. Dhillo
Endocrinology (2021) Vol. 163, Iss. 1
Open Access | Times Cited: 100
Factors Associated with Post-Acute Sequelae of SARS-CoV-2 (PASC) After Diagnosis of Symptomatic COVID-19 in the Inpatient and Outpatient Setting in a Diverse Cohort
Sun M. Yoo, Teresa C. Liu, Yash Motwani, et al.
Journal of General Internal Medicine (2022) Vol. 37, Iss. 8, pp. 1988-1995
Open Access | Times Cited: 92
SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19
Danielle Beckman, Alyssa Bonillas, Giovanne B. Diniz, et al.
Cell Reports (2022) Vol. 41, Iss. 5, pp. 111573-111573
Open Access | Times Cited: 91
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
G. S. Gupta
Inflammation (2022) Vol. 45, Iss. 6, pp. 2091-2123
Open Access | Times Cited: 79
Laser-induced graphene (LIG)-based Au@CuO/V2CTx MXene non-enzymatic electrochemical sensors for the urine glucose test
Feiyun Cui, Haiming Sun, Xueqiong Yang, et al.
Chemical Engineering Journal (2023) Vol. 457, pp. 141303-141303
Closed Access | Times Cited: 79
Association of vitamin D status with COVID-19 and its severity
Jae Hyun Bae, Hun Jee Choe, Michael F. Holick, et al.
Reviews in Endocrine and Metabolic Disorders (2022) Vol. 23, Iss. 3, pp. 579-599
Open Access | Times Cited: 78
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 69
Adherence to Healthy Lifestyle Prior to Infection and Risk of Post–COVID-19 Condition
Siwen Wang, Yanping Li, Yiyang Yue, et al.
JAMA Internal Medicine (2023) Vol. 183, Iss. 3, pp. 232-232
Open Access | Times Cited: 56
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 53
Global Diabetes Prevalence in COVID-19 Patients and Contribution to COVID-19– Related Severity and Mortality: A Systematic Review and Meta-analysis
Rui Li, Mingwang Shen, Qianqian Yang, et al.
Diabetes Care (2023) Vol. 46, Iss. 4, pp. 890-897
Open Access | Times Cited: 40
View on Metformin: Antidiabetic and Pleiotropic Effects, Pharmacokinetics, Side Effects, and Sex-Related Differences
Guglielmina Froldi
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 478-478
Open Access | Times Cited: 14
ACE2: the molecular doorway to SARS-CoV-2
Miriam Marlene Medina-Enríquez, Sandra López‐León, José Alberto Carlos-Escalante, et al.
Cell & Bioscience (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 119
Diabetes and COVID-19: The past, the present, and the future
Raymond Pranata, Joshua Henrina, Wilson Matthew Raffaello, et al.
Metabolism (2021) Vol. 121, pp. 154814-154814
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top